Comparing research-peptide suppliers is difficult when every vendor uses similar descriptive language. The way through is to compare only what can be verified — the documentation and analytical practices behind a material — rather than the marketing around it. This article is a practical, side-by-side framework: a set of documentation-based criteria, what a strong answer looks like for each, and the red flags to watch for. It complements our prose guide to evaluating a supplier's documentation, which explains the reasoning behind each criterion in more depth.
The Comparison Criteria
Apply the same criteria to each supplier and compare their documented answers. The criterion is only useful if you can assess it from records that are available before purchase.
| Criterion | What good looks like | Red flag |
|---|---|---|
| Certificate of Analysis | Lot-specific COA stating identity, purity, appearance, and lot ID, with methods named. | Generic spec sheet not tied to the lot in hand; no COA before purchase. |
| Analytical methods | RP-HPLC for purity and LC-MS for identity, with methods and conditions stated. | A bare purity number with no method, or no identity method at all. |
| Independent third-party testing | A report from a laboratory separate from the supplier, retained with the lot. | No third-party option; or a report that cannot be tied to the specific lot. |
| Lot traceability | A unique lot number linking COA, supporting reports, and the container. | No lot number, or records that cannot be connected to the physical material. |
| Purity reporting | An area-percent value with its method; net peptide content reported separately where relevant. | A round "99%+" with no method, or purity and net content conflated. |
| Storage & handling information | Clear storage conditions and handling guidance consistent with the material. | No storage information, or guidance that reads as consumer instructions. |
| Documentation availability | Records available for review before and after purchase. | Documentation available only on request after payment, or not at all. |
| Research-use framing | Consistent research-use-only labeling; no efficacy, dosing, or health claims. | Benefit, dosing, or human-use claims — a compliance and credibility concern. |
How to Use the Framework
Work down the criteria for each supplier and record what you can actually confirm from their documentation, not what their copy asserts. A supplier that scores well on verifiable criteria — lot-specific COAs, named methods, independent testing, clean traceability — is demonstrating the systems behind its materials. One that scores well only on descriptive language is not giving you anything to check.
Verifiable vs Descriptive
The single most useful habit is to separate the verifiable from the descriptive. "High purity" is descriptive; "99.2% by RP-HPLC under a stated method, with an independent third-party report on the lot" is verifiable. Comparison is only meaningful on the latter — and only when the methods being compared are comparable, a point covered in what 99% purity actually means and independent third-party verification.
What This Framework Does and Does Not Establish
This framework compares how suppliers document and verify their materials. It does not:
- Rank or endorse any specific supplier, named or otherwise.
- Establish that a material is suitable for a particular research workflow — a laboratory determination made against institutional SOPs.
- Make or imply any claim about the effect, activity, or use of any material.
Key Takeaways
- Compare suppliers on verifiable documentation, not marketing language.
- Core criteria: lot-specific COA, named methods, independent third-party testing, traceability, method-bound purity, storage info, availability, and research-use framing.
- Red flags cluster around missing methods, non-lot-specific records, and unverifiable claims.
- Meeting these criteria supports a comparison; it does not establish suitability, which the laboratory determines.